Nicolas Hohmann

Publication Activity (10 Years)

Years Active: 2022-2024
Publications (10 Years): 4

Top Topics

Neoadjuvant Chemotherapy

Small Cell Lung Cancer

Top Venues

Clinical and translational science

Current issues in molecular biology

This page only lists publications with an associated author ORCID identifier.

Publications

Nicolas Hohmann, Anna S Friedrichs, Juergen Burhenne, Antje Blank, Gerd Mikus, Walter Emil Haefeli
Dose-dependent induction of CYP3A activity by St. John's wort alone and in combination with rifampin. Clinical and translational science 17 (8) (2024)
Nicolas Hohmann, Anna S Friedrichs, Juergen Burhenne, Antje Blank, Gerd Mikus, Walter Emil Haefeli
Dose-dependent induction of CYP3A activity by St. John's wort alone and in combination with rifampin. Clinical and translational science 17 (8) (2024)
Nicolas Hohmann, Martin Ronald Sprick, Azaz Ahmed, Juergen Burhenne, Marietta Kirchner, Lucian Le Cornet, Markus Kratzmann, Jacek Hajda, Albrecht Stenzinger, Karen Steindorf, Stefan Delorme, Heinz-Peter Schlemmer, Sabine Riethdorf, Ron van Schaik, Klaus Pantel, Jens Thomas Siveke, Thomas Seufferlein, Dirk Jäger, Walter Emil Haefeli, Flavia Carla Meotti, Christoph Springfeld
Protocol of the IntenSify-Trial: An open-label phase I trial of the CYP3A inhibitor cobicistat and the cytostatics gemcitabine and nab-paclitaxel in patients with advanced stage or metastatic pancreatic ductal adenocarcinoma to evaluate the combination's pharmacokinetics, safety, and efficacy. Clinical and translational science (2023)
Manuela G Neuman, Helmut K Seitz, Rolf Teschke, Stephen Malnick, Kamisha L Johnson-Davis, Lawrence B Cohen, Anit German, Nicolas Hohmann, Bernhardo Moreira, George Moussa, Mihai Opris
Molecular, Viral and Clinical Features of Alcohol- and Non-Alcohol-Induced Liver Injury. Current issues in molecular biology 44 (3) (2022)